Femasys to exhibit at the canadian fertility and andrology society's 70th annual meeting

Atlanta, sept. 05, 2024 (globe newswire) -- femasys, inc., (nasdaq: femy), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic products, announces that the company will be exhibiting at the canadian fertility and andrology society's (cfas) 70th annual meeting, to be held september 12-14, 2024 at the westin bayshore, vancouver, british columbia. the company will be exhibiting at booth #s26.
FEMY Ratings Summary
FEMY Quant Ranking